When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ENTA - Baird likes Enanta's potential in COVID-19 upgrades to Outperform
Enanta Pharmaceuticals Inc.
Citing its know-how in antiviral development and its attractive valuation, Baird has upgraded to Enanta Pharmaceuticals (ENTA-5.3%) to Outperform with a $60 (56% upside) price target. It believes that the company is well-positioned to push a viable candidate for COVID-19 over the finish line. Discovery efforts are underway.
More news on: Enanta Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,